TGA approves MENVEO vaccine to help protect babies from 2 months of age from Meningococcal disease

A Welcome relief to parents of babies today as GSK announces that MENVEO,  (a combination   ACWY vaccine) is available for use in babies from 2 months of age.

This is an significant announcement as we move into our peak season for this disease.

Meningococcal W strain has doubled in number of cases in the last 18 months and is now one of the more prevalent strains in Australia- alongside A,B, C, X and Y. This vaccination is NOT on the National Immunisation Schedule - please speak to your GP about this vaccination.

 

For media enquirers please contact Eliza Ault- Connell 0499092702